Tender detail

Medicines of A16 group

Summary

The tender concerns a framework agreement for the purchase of A16 group medicines, divided into 3 lots. A bid may be submitted for one or more lots, and a single bidder may be awarded up to 3 lots. The bidder must submit the tender form, confirm a valid wholesale medicines licence in Estonia, and ensure the offered medicine has a valid marketing authorisation in Estonia unless the tender documents provide for an exception. The bid must follow the technical requirements in Annex 1, including active substance, original name, dosage form, strength, manufacturer, unit price and total price. The bidder must also accept the exclusion grounds and the sanctions-related compliance conditions set out in the documents.

Reference number
311702-0000
Buyer
sihtasutus Tartu Ülikooli Kliinikum
Country
Estonia (EST)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2026-07-08
Status
Open
Contract subject
Supplies
Estimated value
Not published
Source
RHR

Participation requirements

Tender requirements are available in the official tender documents.

Compliance requirements

The bidder and its management bodies must not have been finally convicted in the last 5 years for participation in a criminal organisation, corruption, fraud or any other exclusion ground listed in the ESPD. If an exclusion ground applies, the bidder may submit evidence of self-cleaning measures where permitted. The ESPD also includes confirmations related to payment of taxes and social security contributions. The exact list of exclusion grounds must be checked in the ESPD and the tender documents.

Qualification criteria and exclusion grounds

The bidder must submit the ESPD and confirm a valid wholesale medicines licence in Estonia. The offered medicine must have a valid marketing authorisation in Estonia; if not, the tender documents describe an exception and the contracting authority will check the authorisation itself in the Medicines Agency register. The bid must be submitted in the Excel form of Annex 1, and the application for participation in the procurement must be submitted on Annex 3, Form II. If the bid is joint, a authorised representative must be appointed and a joint-bidder power of attorney and joint and several liability confirmation must be attached. The bid must comply with the procurement documents, and equivalence must be explained and evidence attached where needed. The bidder must complete the technical data in Annex 1 for the offered medicine: active substance, original name, dosage form, strength, manufacturer, unit price and total price. The procurement has 3 lots, and a bid may be submitted for one or more lots; a contract may be awarded to one bidder for up to 3 lots. The exact exclusion grounds and all other requirements must be checked in the ESPD, the compliance conditions and the tender documents.